| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |